Oracle (ORCL) reported $13.84 billion in revenue for the quarter ended May 2023, representing a year-over-year increase of 16.9%. EPS of $1.67 for the same period compares to $1.54 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $13.74 billion, representing a surprise of +0.71%. The company delivered an EPS surprise of +5.70%, with the consensus EPS estimate being $1.58.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company’s financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock’s price performance more accurately.
Here is how Oracle performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Cloud services and license support: $9.37 billion versus $9.51 billion estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +23.1% change.
- Revenue- Hardware: $850 million compared to the $831.59 million average estimate based on eight analysts. The reported number represents a change of -0.7% year over year.
- Revenue- Services: $1.47 billion versus the eight-analyst average estimate of $1.44 billion. The reported number represents a year-over-year change of +75.9%.
- Revenue- Cloud license and on-premise license: $2.15 billion versus $2.31 billion estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a -15.2% change.
Shares of Oracle have returned +12.3% over the past month versus the Zacks S&P 500 composite’s +4.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Image and article originally from www.nasdaq.com. Read the original article here.